These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23836974)

  • 1. Pregabalin for the treatment of generalized anxiety disorder: an update.
    Baldwin DS; Ajel K; Masdrakis VG; Nowak M; Rafiq R
    Neuropsychiatr Dis Treat; 2013; 9():883-92. PubMed ID: 23836974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pregabalin in the treatment of generalized anxiety disorder.
    Baldwin DS; Ajel K
    Neuropsychiatr Dis Treat; 2007 Apr; 3(2):185-91. PubMed ID: 19300552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin: a review of its use in adults with generalized anxiety disorder.
    Frampton JE
    CNS Drugs; 2014 Sep; 28(9):835-54. PubMed ID: 25149863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.
    Strawn JR; Geracioti TD
    Neuropsychiatr Dis Treat; 2007 Apr; 3(2):237-43. PubMed ID: 19300556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.
    Boschen MJ
    Can J Psychiatry; 2011 Sep; 56(9):558-66. PubMed ID: 21959031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
    Owen RT
    Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.
    Micó JA; Prieto R
    CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
    Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE; Foster RH
    CNS Drugs; 2006; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.
    Stein DJ; Baldwin DS; Baldinetti F; Mandel F
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):422-30. PubMed ID: 18359203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing.
    Pohl RB; Feltner DE; Fieve RR; Pande AC
    J Clin Psychopharmacol; 2005 Apr; 25(2):151-8. PubMed ID: 15738746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pregabalin on sleep in generalized anxiety disorder.
    Holsboer-Trachsler E; Prieto R
    Int J Neuropsychopharmacol; 2013 May; 16(4):925-36. PubMed ID: 23009881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.
    Both C; Kojda G; Lange-Asschenfeldt C
    Expert Rev Neurother; 2014 Jan; 14(1):29-38. PubMed ID: 24308277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of pregabalin in partial epilepsy.
    Beydoun A; Nasreddine W; Atweh S
    Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.
    Millan MJ
    Ther Adv Psychopharmacol; 2022; 12():20451253221105128. PubMed ID: 35795687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Antidepressant Treatment of Generalized Anxiety Disorder.
    Zahreddine N; Richa S
    Curr Clin Pharmacol; 2015; 10(2):86-96. PubMed ID: 23438725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.